Ultrapar. Equity Research. Crisis...what crisis? BTG Pactual Global Research. Latin America Oil, Gas & Petrochemicals Company Note 05 November 2015



Similar documents
Copel. Equity Research. Weak Q1 results. BTG Pactual Global Research. Latin America Electric & Other Utilities Company Note 13 May 2016

Terrafina. Equity Research. Terra kicks off acquisition spree with US$108m purchase. BTG Pactual Global Research. Latin America

RUMO. Equity Research. Positive feedback from Investor Day

Walmex. Equity Research. 4Q15 A miss, no signs of operating leverage. BTG Pactual Global Research

Cemex LatAm Holdings. Equity Research. 3Q15: Another disappointing quarter. BTG Pactual Global Research

Macroeconomic Research Brazil External Sector

Lojas Americanas. Equity Research. Better than expected B&M results; B2W hurts bottom line

Lojas Americanas. Equity Research. B&M as resilient as it gets; B2W s bottom line hurt results

Lojas Americans / B2W

Gerdau. Equity Research. 4Q15: Weak results, but FCF impresses

Ecopetrol. Equity Research. Still a dividend play? Latin America Oil, Gas & Petrochemicals Company Note 06 March 2015

Petrobras. Equity Research. When no news is good news. Latin America Oil, Gas & Petrochemicals Company Note 19 January 2015

CETIP. Equity Research. December data indicate a decent Q4 ahead, but all eyes are still on M&A newsflow

Equity Research. Chile releases lithium policy; will tender some reserves. BTG Pactual Affiliate Research Banco BTG Pactual S.A.

Brazilian Mobile Market

Petrobras. Equity Research. Mapping the production curve. BTG Pactual Global Research

Brazilian Auto Insurance

Brazilian Auto Insurance

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Macroeconomic Research Brazil Public Finance

Macroeconomic Research Chile Quarterly Review

Gujarat State Petronet Ltd. INR 135

INVESTMENT CASE FULLY INTACT

euromicron AG Corrections to financial statements Hold EUR

Brazilian Insurance Sector

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

Longfor (960 HK) Unrated Real Estate Development Industry

Why ECB QE is Negative for Commodities. Investment Research & Advisory. Deltec International Group

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

CEWE Stiftung & Co. KGaA

Petrel Energy Ltd. This report is intended for Unauthorized redistribution of this report is prohibited.

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14

Private drilling fluid technology service leader

GAIL (India) Ltd. INR 346

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Company Overview. Financial Performance

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3

Company Report. New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.

Britannia Industries

The Ramco Cements. Source: Company Data; PL Research

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

Bright Smart (1428 HK)

FIRST CAPITAL. Sound 2014 results and attractive dividend. Buy (maintained) Company Update

MATELAN Research. Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES

Closed-end fund update

Flexituff International Ltd. (FIL)

potential of business still not fully exploited; PT raised to Q results vs. estimates IFRS Q3 15 Q2 15 qoq Q3 14 yoy Q3 15e delta

Empresaria (EMR.L) Empressive finish to the year

The Merchant Securities FTSE 100. Hindsight II Note PRIVATE CLIENT ADVISORY

Maruti Suzuki. Source: Company Data; PL Research

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Trends and Technology A Capital Markets Perspective

Background information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years

G5 Entertainment. G5 Entertainment. Quarter Update Q3 15. Amended strategy and boosted profitability

Oracle Corp. (ORCL) Sounds like we should forget about move to subscription accounting. The Goldman Sachs Group, Inc.

OptimizeRx OPRX. Buy. Platform Potential Continues to Grow $0.87 $4.00. Refer to the last two pages of this report for Disclosures

Rating Action: Moody's assigns Aaa.br rating to Duke's BRL479 million debentures; outlook stable

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

GlaxoSmithKline Consumer Healthcare

China Property Sector Expecting lower policy risk due to stabilizing home prices

Quant Picks United Breweries

European Freight Forwarding Index

DAILY TECHNICAL REPORT

Aoyuan (3883 HK) Site visit to Guangzhou: Key takeaways

Strong operational performance

SK Networks ( KS)

Commodities. Precious metals as an asset class. April What qualifies as an asset class? What makes commodities an asset class?

2 September 2015 YOC AG. FIRST BERLIN Equity Research

BDI BioEnergy Internat Buy

Tetragon Financial Group Limited ( TFG )

DAILY TECHNICAL REPORT

A Financial Analysis of Energies and Gas Pipelines

Master Limited Partnerships (MLPs)

E 2013E 2014E

DO WE NEED MORE STORAGE IN EUROPE?

2015 Budget RPM Continues its Focus on High Potential Targets

Morning Buzz. Research Picks INDIA. India IT Services: Mixed quarter from Accenture. 21 December 2015

Keyware Technologies N.V- valuation highlights

Khambatta Securities Ltd.

Homex - Downgrading vs. Upgrading

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

How To Understand The Performance Of An International Consulting Firm

Fidelity Bankshares, Inc.

Jubilant Life Sciences

Deutsche Bank Global Transaction Banking. What DR investors are buying: An analysis of investment drivers for depositary receipts

Seeking Alternatives. Senior loans an innovative asset class

QE, Credit Markets and Bubbles

Palangana expansion fully permitted; Burke Hollow receives disposal well permit. Associate: Michael Wichterle, MBA,

22 December 2015 YOC AG. FIRST BERLIN Equity Research

When the going get tough...

HCC BUY. Infrastructure January 29, 2016

KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES

price target of We reiterate our Buy rating. Figure 1: Reported figures versus forecasts Source: First Berlin Equity Research, SFC Energy AG

20 May 2015 OpenLimit Holding AG. FIRST BERLIN Equity Research

Aurobindo Pharma. Source: Company Data; PL Research

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Transcription:

Equity Research BTG Pactual Global Research Crisis...what crisis? Solid, in-line Q3 figures reported another strong set of results. Revenues of R$19.1bn were slightly better than our R$19.0bn, EBITDA of R$944mn was in line with our R$950mn, and net earnings of R$299mn matched our figure. Despite the crisis that has been affecting most of the country s industries (and companies), s business mix helped it navigate the storm and grow its EBITDA 20% y/y, a stunning achievement in today's world. Ipiranga volumes still sagging; Oxiteno is booming! The negative side of the numbers (already highlighted by Sindicom s monthly reports) was the deceleration in Ipiranga s volume growth (up only 0.5% y/y this quarter). But although the company has been able to expand its fuel distribution margins, the macro environment is capping the growth potential of UGP s biggest business. Elsewhere, Oxiteno enjoyed another very strong quarter, with EBITDA soaring 115% y/y to R$212mn on the back of BRL depreciation. We had R$232mn and this -8% difference is explained by a higher variable compensation payment that we weren t considering in our SG&A. Please find the comparison per business in the table below. Latin America Oil, Gas & Petrochemicals Company Note 05 November 2015 Rating 12m Price Target Price RIC: UGPA3.SA, BBG: UGPA3 BZ Trading Data and Return Forecasts Neutral R$67.00/US$17.63 R$69.33/US$18.25 52-wk range R$72.97-47.83/US$24.35-8.24 Market cap. R$38,576m/US$10,152m Shares o/s (m) 556.4 Free float - Avg. daily volume('000 Shares) 1,632 Avg. daily value (R$ m) 107.6 Forecast price appreciation -3.4% Forecast dividend yield 1.2% Forecast stock return -2.2% Stock Performance (R$) 80.0 60.0 40.0 120 90 60 Initiatives to keep an eye on This quarter, opened its first Extrafarma store in an Ipiranga fuel station. With retail operations in 12k locations (Ipiranga or Ultragaz), this is an important step to track in order to better understand the real value of the pharmacy distribution business. also announced the expansion of its Oxiteno plant in the US (Pasadena), with an expected capex of US$113mn. Great company...tough macro environment...rich multiples; staying Neutral Despite a vibrant business mix, we think multiples already accurately reflect the investment case positives and macro crisis negatives. Our TP is DCF-derived, discounted at a real 8% WACC rate. Valuation 12/2013 12/2014 12/2015E 12/2016E 12/2017E RoIC (EBIT) % 22.1 20.8 22.6 23.4 24.9 EV/EBITDA 11.6 10.3 11.3 10.2 9.5 P/E 24.9 23.1 26.5 22.9 20.3 Net dividend yield % 2.3 2.7 2.3 2.6 2.9 Financials (R$mn) 12/2013 12/2014 12/2015E 12/2016E 12/2017E Revenues 60,940 67,736 74,529 79,305 82,196 EBITDA 2,918 3,158 3,855 4,215 4,465 Net Income 1,225 1,242 1,456 1,688 1,896 EPS (R$) 2.25 2.23 2.62 3.03 3.41 Net DPS (R$) 1.30 1.40 1.59 1.82 2.04 Net (debt) / cash (3,426) (3,975) (5,156) (4,430) (3,746) Source: Company reports, Bovespa, BTG Pactual S.A. estimates. / Valuations: based on the last share price of the year; (E) based on a share price of R$69.33, on 04 November 2015. 20.0 0.0 5-Nov-12 5-Feb-13 5-May-13 5-Aug-13 5-Nov-13 5-Feb-14 5-May-14 5-Aug-14 5-Nov-14 5-Feb-15 5-May-15 5-Aug-15 Price Target (R$) Stock Price (R$) Rel. Ibovespa Antonio Junqueira, CFA New York BTG Pactual US Capital LLC antonio.junqueira@btgpactual.com +1 646 924 2476 Julia Ozenda Brazil Banco BTG Pactual S.A. julia.ozenda@btgpactual.com +55 21 3262-8636 Andres Cardona Colombia - BTG Pactual andres.cardona@btgpactual.com +574 356 7421 5-Nov-15 30 0 ANALYST CERTIFICATION AND REQUIRED DISCLOSURES BEGIN ON PAGE 4 Banco BTG Pactual S.A. does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Any U.S. person receiving this report and wishing to effect any transaction in a security discussed in this report should do so with BTG Pactual US Capital, LLC at 212-293-4600, 601 Lexington Avenue. 57th Floor, New York NY 10022.

05 November 2015 page 2 Table 1: s actual vs. expected 3Q15 results R$m 3Q15 3Q15E Diff YoY QoQ 2Q15 3Q14 Net revenues 19,161 19,036 0.7% 10.8% 3.5% 18,511 17,300 EBITDA 944 950-0.6% 19.6% 11.6% 846 789 Ultragaz 103 84 22.5% 15.6% 41.8% 73 89 Oxiteno 212 231-8.1% 114.8% 4.5% 203 99 Ultracargo 14 20-27.7% -67.5% -129.6% (49) 44 Ipiranga 610 615-0.7% 9.6% 6.0% 576 557 Extrafarma 6 10-39.6% 266.0% -33.6% 9 2 Others (2) (10) -79.0% 44.0% -106.1% 34 (1) EBIT 691 707-2.1% 22.3% 15.6% 598 565 (-) Fin. and others (234) (269) -12.8% 125.1% 93.1% (121) (104) (-) Taxes (159) (136) 16.8% 19.6% 8.7% (146) (133) (-) Minorities (3) (3) -11.5% 2.3% 5.8% (3) (3) Net income 299 299-0.1% -8.3% -9.0% 329 326 EPS (R$) 0.53 0.54-1.1% -9.3% -9.9% 0.59 0.59 Capex 374 398-6.1% 2.0% 21.3% 308 367 Net debt 5,659 4,794 18.0% 29.6% 13.5% 4,984 4,367 Ipiranga Vol. grow th (%) 0.5% 1.5% -96bp -169bp -18bp 2.2% 0.7% EBITDA ($/m3) 93 93 0% 9% 4% 85 89 Source: BTG Pactual and Company Reports

05 November 2015 page 3 Income Statement (R$mn) 12/2010 12/2011 12/2012 12/2013 12/2014 12/2015E 12/2016E 12/2017E Revenue 42,482 48,661 53,919 60,940 67,736 74,529 79,305 82,196 Operating expenses (ex depn) (40,705) (46,651) (51,518) (58,022) (64,578) (70,674) (75,090) (77,731) EBITDA (BTG Pactual) 1,776 2,011 2,402 2,918 3,158 3,855 4,215 4,465 Depreciation (542) (580) (696) (814) (908) (1,002) (1,045) (1,093) Operating income (EBIT, BTG Pactual) 1,235 1,431 1,705 2,104 2,250 2,854 3,170 3,372 Other income & associates 90 22 4 35 20 25 0 0 Net Interest (264) (297) (262) (338) (445) (748) (709) (609) Abnormal items (pre-tax) 0 0 0 0 0 0 0 0 Profit before tax 1,060 1,156 1,447 1,801 1,825 2,131 2,461 2,763 Tax (295) (295) (427) (573) (573) (665) (763) (857) Profit after tax 765 861 1,020 1,229 1,251 1,466 1,698 1,907 Abnormal items (post-tax) 0 0 0 0 0 0 0 0 Minorities / pref dividends (0) (6) (7) (4) (10) (10) (10) (10) Net Income (local GAAP) 765 855 1,013 1,225 1,242 1,456 1,688 1,896 Adjusted Net Income 765 855 1,013 1,225 1,242 1,456 1,688 1,896 Tax rate (%) 28 26 30 32 31 31 31 31 Per Share 12/2010 12/2011 12/2012 12/2013 12/2014 12/2015E 12/2016E 12/2017E EPS (local GAAP) 5.62 1.57 1.86 2.25 2.23 2.62 3.03 3.41 EPS (BTG Pactual) 5.62 1.57 1.86 2.25 2.23 2.62 3.03 3.41 Net DPS 0.79 0.92 1.00 1.30 1.40 1.59 1.82 2.04 BVPS 37.87 10.24 11.05 12.03 13.89 15.10 16.32 17.68 Cash Flow (R$mn) 12/2010 12/2011 12/2012 12/2013 12/2014 12/2015E 12/2016E 12/2017E Net Income 765 855 1,013 1,225 1,242 1,456 1,688 1,896 Depreciation 542 580 696 814 908 1,002 1,045 1,093 Net change in working capital (245) (353) (33) (651) (305) (1,101) 5 (158) Other (operating) (16) (94) 66 199 (363) 7 10 10 Net cash from operations 1,045 987 1,742 1,587 1,483 1,363 2,748 2,841 Cash from investing activities (815) (1,084) (1,491) (1,119) (1,998) (1,363) (1,010) (1,019) Cash from financing activities 714 (336) 128 20 1,372 (711) (1,013) (1,138) Bal sheet chge in cash & equivalents 944 (438) 379 382 856 (1,088) 726 685 Balance Sheet (R$mn) 12/2010 12/2011 12/2012 12/2013 12/2014 12/2015E 12/2016E 12/2017E Cash and equivalents 3,220 2,782 3,162 3,544 4,400 3,312 4,038 4,723 Other current assets 3,257 3,868 4,164 4,479 5,233 6,266 6,260 6,458 Total current assets 6,477 6,650 7,326 8,022 9,633 9,579 10,298 11,181 Net tangible fixed assets 5,349 5,818 6,670 7,029 8,250 8,726 8,691 8,617 Net intangible fixed assets 0 0 0 0 0 0 0 0 Investments / other assets 1,163 1,275 1,304 1,327 1,597 1,669 1,669 1,669 Total assets 12,990 13,743 15,300 16,379 19,480 19,974 20,658 21,467 Trade payables & other ST liabilities 1,698 1,793 2,108 1,935 2,250 1,866 1,865 1,905 Short term debt 821 2,305 1,641 1,830 3,442 2,003 2,003 2,003 Total current liabilities 2,518 4,098 3,749 3,764 5,692 3,869 3,868 3,907 Long term debt 4,576 3,257 4,598 5,140 4,933 6,465 6,465 6,465 Other long term liabilities 721 811 937 928 1,129 1,231 1,231 1,231 Total liabilities 7,814 8,166 9,284 9,832 11,754 11,565 11,564 11,604 Equity & minority interests 5,176 5,577 6,016 6,547 7,727 8,409 9,094 9,863 Total liabilities & equities 12,990 13,743 15,300 16,379 19,480 19,974 20,658 21,467 Company Profile: is a Brazilian industrial group that focuses on three key markets: petrochemicals (ethylene oxide, ethylene glycol and specialities production); LPG distribution; and logistics for hazardous materials. went public in 1999 and is jointly controlled by the Pery Igel family and its management team. shareholders' agreement and bylaws ensure that minority shareholders will receive equal treatment in the event of any change in control of the company. Financial ratios 12/2013 12/2014 12/2015E 12/2016E 12/2017E EBITDA margin 4.8% 4.7% 5.2% 5.3% 5.4% Operating margin 3.5% 3.3% 3.8% 4.0% 4.1% Net margin 2.0% 1.8% 2.0% 2.1% 2.3% RoE 19.5% 17.4% 18.1% 19.3% 20.1% RoIC 22.1% 20.8% 22.6% 23.4% 24.9% EBITDA / net interest 8.6x 7.1x 5.2x 5.9x 7.3x Net debt / EBITDA 1.2x 1.3x 1.3x 1.1x 0.8x Total debt / EBITDA 2.4x 2.7x 2.2x 2.0x 1.9x Net debt / (net debt + equity) 34.4% 34.0% 38.0% 32.8% 27.5% Source: Company reports and BTG Pactual estimates. Valuations: based on the last share price of that year(e) based on share price as of 04 November 2015

05 November 2015 page 4 Required Disclosures This report has been prepared by BTG Pactual US Capital LLC. The figures contained in performance charts refer to the past; past performance is not a reliable indicator of future results. BTG Pactual Rating Buy Neutral Sell Definition Coverage *1 IB Services *2 Expected total return 10% above the company s sector average. Expected total return between +10% and -10% the company s sector average. Expected total return 10% below the company s sector average. 44% 45% 51% 44% 5% 33% 1: Percentage of companies under coverage globally within the 12-month rating category. 2: Percentage of companies within the 12-month rating category for which investment banking (IB) services were provided within the past 12 months. Absolute return requirements Besides the abovementioned relative return requirements, the listed absolute return requirements must be followed: a) a Buy rated stock must have an expected total return above 15% b) a Neutral rated stock can not have an expected total return below -5% c) a stock with expected total return above 50% must be rated Buy Analyst Certification Each research analyst primarily responsible for the content of this investment research report, in whole or in part, certifies that: (i) all of the views expressed accurately reflect his or her personal views about those securities or issuers, and such recommendations were elaborated independently, including in relation to BTG Pactual US or its affiliates, as the case may be; (ii) no part of his or her compensation was, is, or will be, directly or indirectly, related to any specific recommendations or views contained herein or linked to the price of any of the securities discussed herein. The research analyst responsible for this report is registered/qualified as a research analysts by FINRA. It is possible that research analysts contributing to this report are employed by a non-us broker-dealer. In this case the analysts will not be registered/qualified as research analysts under FINRA rules and therefore will not be subject to the restrictions contained in the FINRA rules regarding communications with a subject company, public appearances, and financial interest in the securities of the subject company. Part of the analyst compensation comes from the profits of BTG Pactual US or its affiliates as a whole and/or its affiliates and, consequently, revenues arisen from transactions held by BTG Pactual US or its affiliates. Statement of Risk is subject to a number of risks relating to commodity prices, exchange rates and on time implementation of new projects. The most relevant risks to our estimates relate to significant compression of petrochemical margins, the appreciation of Brazil's currency and 's ability to raise the margins the company has on its recently acquired fuel distribution business. Valuation Methodology Participações [BRUGP] (Primary) - has a top quality management but is highly impacted by macro environment, thus we assume a slowdown in sector sales in 2015 and long term fuel sales of 2%. Our price target is DCF-derived, discounted at a real WACC rate Company Disclosures Company Name Reuters 12-mo rating Price Price date 1, 2, 4, 6, 18, 19, 20 UGPA3.SA Neutral R$69.33 4-11-2015 1. Within the past 12 months, BTG Pactual US or its affiliates has received compensation for investment banking services from this company/entity. 2. BTG Pactual US or its affiliates expect to receive or intend to seek compensation for investment banking services and/or products and services other than investment services from this company/entity within the next three months. 4. This company/entity is, or within the past 12 months has been, a client of BTG Pactual US or its affiliates, and investment banking services are being, or have been, provided. 6. BTG Pactual US and/or its affiliates receive compensation for any services rendered or presents any commercial relationships with this company, entity or person, entities or funds which represents the same interest of this company/entity. 18. As of the end of the month immediately preceding the date of publication of this report, neither BTG Pactual US nor its affiliates or subsidiaries beneficially owned 1% or more of a class of this company`s common equity securities. 19. Neither BTG Pactual US nor its affiliates or subsidiaries have managed or co-managed a public offering of securities for the company. 20. Neither BTG Pactual US nor its affiliates or subsidiaries engaged in market making activities in the subject company s securities at the time this research was report was published.

05 November 2015 page 5 80.0 Stock Price (R$) Price Target (R$) 60.0 40.0 20.0 0.0 5-Nov-12 5-Feb-13 5-May-13 5-Aug-13 5-Nov-13 5-Feb-14 5-May-14 5-Aug-14 5-Nov-14 5-Feb-15 5-May-15 5-Aug-15 5-Nov-15 Buy Neutral Sell No Rating Source: BTG Pactual and Economatica. Prices as of 04 November 2015

05 November 2015 page 6 Global Disclaimer This report has been prepared by BTG Pactual US Capital LLC ( BTG Pactual US, ), a broker-dealer registered with the U.S. Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation, and BTG Pactual US is distributing this report in the United States. BTG Pactual US is an affiliate of Banco BTG Pactual S.A, a Brazilian regulated bank. BTG Pactual US assumes responsibility for this research for purposes of U.S. law. Any U.S. person receiving this report and wishing to effect any transaction in a security discussed in this report should do so with BTG Pactual US at 212-293-4600, 601 Lexington Ave. 57th Floor, New York, NY 10022. This report is being distributed in the United Kingdom and elsewhere in the European Economic Area ( EEA ) by BTG Pactual Europe LLP ( BTG Pactual UK ), which is authorized and regulated by the Financial Services Authority of the United Kingdom. This report may also be distributed in the United Kingdom and elsewhere in the EEA by BTG Pactual S.A. and/or BTG Pactual US. BTG Pactual UK has not: (i) produced this report, (ii) substantially altered its contents, (iii) changed the direction of the recommendation, or (iv) disseminated this report prior to its issue by BTG Pactual US. BTG Pactual UK does not distribute summaries of research produced by BTG Pactual US. BTG Pactual Chile S.A. Corredores de Bolsa ( BTG Pactual Chile ), formerly known as Celfin Capital S.A. Corredores de Bolsa, a Chilean broker dealer registered with Superintendencia Valores Y Seguros (SVS) in Chile and responsible for the distribution of this report in Chile and BTG Pactual Perú S.A. Sociedad Agente de Bolsa ( BTG Pactual Peru ), formerly known as Celfin Capital S.A. Sociedad Agente de Bolsa, registered with Superintendencia de Mercado de Valores (SMV) of Peru, is responsible for the distribution of this report in Peru. BTG Pactual Chile and BTG Pactual Peru acquisition by BTG Pactual S.A. was approved by the Brazilian Central Bank on November 14th, 2012. BTG Pactual S.A. Comisionista de Bolsa ( BTG Pactual Colombia ) formerly known as Bolsa y Renta S.A. Comisionista de Bolsa, is a Colombian broker dealer register with the Superintendencia Financeira de Colombia. BTG Pactual Colombia acquisition by BTG Pactual S.A. was approved by Brazilian Central Bank on December 21st, 2012. References herein to BTG Pactual include Banco BTG Pactual S.A., BTG Pactual US Capital LLC, BTG Pactual Europe LLP, BTG Pactual Chile, BTG Pactual Peru and BTG Pactual Colombia. This report is for distribution only under such circumstances as may be permitted by applicable law. This report is not directed at you if BTG Pactual is prohibited or restricted by any legislation or regulation in any jurisdiction from making it available to you. You should satisfy yourself before reading it that BTG Pactual is permitted to provide research material concerning investments to you under relevant legislation and regulations. Nothing in this report constitutes a representation that any investment strategy or recommendation contained herein is suitable or appropriate to a recipient s individual circumstances or otherwise constitutes a personal recommendation. It is published solely for information purposes, it does not constitute an advertisement and is not to be construed as a solicitation, offer, invitation or inducement to buy or sell any securities or related financial instruments in any jurisdiction. Prices in this report are believed to be reliable as of the date on which this report was issued and are derived from one or more of the following: (i) sources as expressly specified alongside the relevant data; (ii) the quoted price on the main regulated market for the security in question; (iii) other public sources believed to be reliable; or (iv) BTG Pactual 's proprietary data or data available to BTG Pactual. All other information herein is believed to be reliable as of the date on which this report was issued and has been obtained from public sources believed to be reliable. No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein, except with respect to information concerning Banco BTG Pactual S.A., its subsidiaries and affiliates, nor is it intended to be a complete statement or summary of the securities, markets or developments referred to in the report. In all cases, investors should conduct their own investigation and analysis of such information before taking or omitting to take any action in relation to securities or markets that are analyzed in this report. BTG Pactual does not undertake that investors will obtain profits, nor will it share with investors any investment profits nor accept any liability for any investment losses. Investments involve risks and investors should exercise prudence in making their investment decisions. BTG Pactual accepts no fiduciary duties to recipients of this report and in communicating this report is not acting in a fiduciary capacity. The report should not be regarded by recipients as a substitute for the exercise of their own judgment. Opinions, estimates, and projections expressed herein constitute the current judgment of the analyst responsible for the substance of this report as of the date on which the report was issued and are therefore subject to change without notice and may differ or be contrary to opinions expressed by other business areas or groups of BTG Pactual as a result of using different assumptions and criteria. Because the personal views of analysts may differ from one another, Banco BTG Pactual S.A., its subsidiaries and affiliates may have issued or may issue reports that are inconsistent with, and/or reach different conclusions from, the information presented herein. Any such opinions, estimates, and projections must not be construed as a representation that the matters referred to therein will occur. Prices and availability of financial instruments are indicative only and subject to change without notice. Research will initiate, update and cease coverage solely at the discretion of BTG Pactual Investment Bank Research Management. The analysis contained herein is based on numerous assumptions. Different assumptions could result in materially different results. The analyst(s) responsible for the preparation of this report may interact with trading desk personnel, sales personnel and other constituencies for the purpose of gathering, synthesizing and interpreting market information. BTG Pactual is under no obligation to update or keep current the information contained herein, except when terminating coverage of the companies discussed in the report. BTG Pactual relies on information barriers to control the flow of information contained in one or more areas within BTG Pactual, into other areas, units, groups or affiliates of BTG Pactual. The compensation of the analyst who prepared this report is determined by research management and senior management (not including investment banking). Analyst compensation is not based on investment banking revenues, however, compensation may relate to the revenues of BTG Pactual Investment Bank as a whole, of which investment banking, sales and trading are a part. The securities described herein may not be eligible for sale in all jurisdictions or to certain categories of investors. Options, derivative products and futures are not suitable for all investors, and trading in these instruments is considered risky. Mortgage and asset-backed securities may involve a high degree of risk and may be highly volatile in response to fluctuations in interest rates and other market conditions. Past performance is not necessarily indicative of future results. If a financial instrument is denominated in a currency other than an investor s currency, a change in rates of exchange may adversely affect the value or price of or the income derived from any security or related instrument mentioned in this report, and the reader of this report assumes any currency risk. This report does not take into account the investment objectives, financial situation or particular needs of any particular investor. Investors should obtain independent financial advice based on their own particular circumstances before making an investment decision on the basis of the information contained herein. For investment advice, trade execution or other enquiries, clients should contact their local sales representative. Neither BTG Pactual nor any of its affiliates, nor any of their respective directors, employees or agents, accepts any liability for any loss or damage arising out of the use of all or any part of this report. Notwithstanding any other statement in this report, BTG Pactual UK does not seek to exclude or restrict any duty or liability that it may have to a client under the regulatory system in the UK (as such term is defined in the rules of the Financial Services Authority). Any prices stated in this report are for information purposes only and do not represent valuations for individual securities or other instruments. There is no representation that any transaction can or could have been effected at those prices and any prices do not necessarily reflect BTG Pactual internal books and records or theoretical model-based valuations and may be based on certain assumptions. Different assumptions, by BTG Pactual S.A., BTG Pactual US, BTG Pactual UK, BTG Pactual Chile and BTG Pactual Peru and Bolsa y Renta S.A. or any other source, may yield substantially different results. This report may not be reproduced or redistributed to any other person, in whole or in part, for any purpose, without the prior written consent of BTG Pactual and BTG Pactual accepts no liability whatsoever for the actions of third parties in this respect. Additional information relating to the financial instruments discussed in this report is available upon request. BTG Pactual and its affiliates have in place arrangements to manage conflicts of interest that may arise between them and their respective clients and among their different clients. BTG Pactual and its affiliates are involved in a full range of financial and related services including banking, investment banking and the provision of investment services. As such, any of BTG Pactual or its affiliates may have a material interest or a conflict of interest in any services provided to clients by BTG Pactual or such affiliate. Business areas within BTG Pactual and among its affiliates operate independently of each other and restrict access by the particular individual(s) responsible for handling client affairs to certain areas of information where this is necessary in order to manage conflicts of interest or material interests. Any of BTG Pactual and its affiliates may: (a) have disclosed this report to companies that are analyzed herein and subsequently amended this report prior to publication; (b) give investment advice or provide other services to another person about or concerning any securities that are discussed in this report, which advice may not necessarily be consistent with or similar to the information in this report; (c) trade (or have traded) for its own account (or for or on behalf of clients), have either a long or short position in the securities that are discussed in this report (and may buy or sell such securities), with the securities that are discussed in this report; and/or (d) buy and sell units in a collective investment scheme where it is the trustee or operator (or an adviser) to the scheme, which units may reference securities that are discussed in this report. United Kingdom and EEA: Where this report is disseminated in the United Kingdom or elsewhere in the EEA by BTG Pactual UK, this report is issued by BTG Pactual UK only to, and is directed by BTG Pactual UK only at, persons who are professional clients or eligible counterparties, each as defined in the rules of the Financial Services Authority (together, referred to as relevant persons ). Where this report is disseminated in the UK by BTG Pactual, this report is issued only to and directed only at persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc") of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). This report is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this report relates is available only to relevant persons and will be engaged in only with relevant persons. Dubai: This research report does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any securities or investment products in the UAE (including the Dubai International Financial Centre) and accordingly should not be construed as such. Furthermore, this information is being made available on the basis that the recipient acknowledges and understands that the entities and securities to which it may relate have not been approved, licensed by or registered with the UAE Central Bank, Emirates Securities and Commodities Authority or the Dubai Financial Services Authority or any other relevant licensing authority or governmental agency in the UAE. The content of this report has not been approved by or filed with the UAE Central Bank or Dubai Financial Services Authority. United Arab Emirates Residents: This research report, and the information contained herein, does not constitute, and is not intended to constitute, a public offer of securities in the United Arab Emirates and accordingly should not be construed as such. The securities are only being offered to a limited number of sophisticated investors in the UAE who (a) are willing and able to conduct an

05 November 2015 page 7 independent investigation of the risks involved in an investment in such securities, and (b) upon their specific request. The securities have not been approved by or licensed or registered with the UAE Central Bank or any other relevant licensing authorities or governmental agencies in the UAE. This research report is for the use of the named addressee only and should not be given or shown to any other person (other than employees, agents or consultants in connection with the addressee's consideration thereof). No transaction will be concluded in the UAE and any enquiries regarding the securities should be made with BTG Pactual CTVM S.A. at +55 11 3383-2638, Avenida Brigadeiro Faria Lima, 3477, 14th floor, São Paulo, SP, Brazil, 04538-133.